BioTechnique Announces Successful DEA Licensing
New license expands BioTechnique’s capabilities in controlled‑substance manufacturing and secure pharmaceutical development. YORK, PA, UNITED STATES, March 17, 2026 /EINPresswire.com/ -- BioTechnique is pleased to announce the successful …